Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Terminated 4Completed 3Suspended 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Classical hematology 2Plasma cell 1Other solid neoplasm 1Gynecologic 1CNS 1

Conditions

Thrombocytopenia 2Solid Tumor 1Ovarian Neoplasms 1Neoplasms 1Multiple Myeloma 1Glioblastoma 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 144Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Terminated × romiplostim × Clear all
NCT04671901 2025-05-28

A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Terminated
2 enrolled 4 charts
Other solid neoplasm

Solid Tumor

NCT03622931 2021-02-08

TRACEII

Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH

Phase 2 Terminated
21 enrolled
Gynecologic

Neoplasms, Ovarian Neoplasms

NCT01676961 2018-10-15

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy

NYU Langone Health

Phase 2 Terminated
5 enrolled 4 charts
Classical hematologyPlasma cell

Multiple Myeloma, Thrombocytopenia

NCT02227576 2018-04-25

PLATUM

University Hospital, Lille

Phase 2 Terminated
20 enrolled
CNSClassical hematology

Glioblastoma, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡